Complicated Urinary Tract Infections Treatment Market

Demand for complicated urinary tract infections treatment will increase through 2036, with cephalosporin at 36.5% of the drug class segment in 2026. The market was valued at USD 10.3 million in 2025 and is expected to reach USD 19.8 million by 2036, creating an incremental opportunity of USD 8.8 million.